The 33rd Annual Meeting of the Society for Medical Decision Making: Author Index B

Author Index: B

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Bachelot, T.

TR1-2 FACTORS INFLUENCING PHYSICIANS' THERAPEUTIC DECISION WHEN PRESCRIBING CHEMOTHERAPY: A DISCRETE CHOICE EXPERIMENT

Bai, Y.

42 COST-EFFECTIVENESS OF A HYPERTENSION CONTROL INTERVENTION IN THREE CHINESE COMMUNITY HEALTH CENTERS

Baik, S. H.

42 COST-EFFECTIVENESS OF MEDICARE PART D PLANS IN SCHIZOPHRENIA

Bailey, S. L.

58 MICROSIMULATION AND CALIBRATION METHODS ACCOUNTING FOR OBESITY AND UNDERWEIGHT-RELATED HEALTH IN COUNTRIES LIKE INDIA

Bajaj, P. S.

1 * A RISK-BENEFIT ANALYSIS OF FACTOR V LEIDEN TESTING TO IMPROVE PREGNANCY OUTCOMES AMONG HIGH-RISK WOMEN

Banerjee, R.

53 IMPROVING THE EFFICIENCY OF THE ANALYTIC HIERARCHY PROCESS

Bansback, N.

30 VALUE CLARIFICATION IN DECISION AIDS: A MISSING ELEMENT?

Barg, F. A.

9 NAMING THE DOWNSIDES OF SURGERY: RACIAL AND GENDER VARIATIONS IN PERCEIVED HAZARDS OF SURGICAL CARE

Barnard, J.

D-2 WHO IS GUIDING DECISIONS ABOUT WHETHER TO PERFORM PEDIATRIC GASTRIC FUNDOPLICATION?

Barnato, A. E.

11 COST-EFFECTIVENESS OF A HYPOTHETICAL INTERVENTION TO IMPROVE PHYSICIAN COMPLIANCE WITH TRAUMA TRIAGE GUIDELINES

Barra, M.

57 WINTDRAWN - A NOVEL JOINT HEALTH-STATE TARIFF-VALUE PREDICTOR BASED ON UNITS OF MORBIDITY

Barton, P. M.

55 USE OF RICHARDSON'S EXTRAPOLATION TO REDUCE TIMING ERRORS IN MARKOV MODELS

Basu, A.

33 EVALUATING A PROPOSED SWOG TRIAL OF BREAST CANCER TUMOR MARKERS: A VALUE OF RESEARCH AND BIOBANK ANALYSIS

36 MINIMAL MODELING APPROACHES TO VALUE OF INFORMATION ANALYSIS

BEHAVIORAL ECONOMICS SYMPOSIUM: FROM A NUDGE TO A SHOVE: HOW BIG A ROLE FOR SHARED DECISION MAKING

O-3 SYSTEMATIZING THE USE OF VALUE OF INFORMATION ANALYSIS FOR PRIORITIZING SYSTEMATIC REVIEWS

TR2 CONCURRENT PRESENTATION OF TOP-RANKED ABSTRACTS - 2 - HEALTH SERVICES, ECONOMICS AND POLICY

Bauza, C.

8 MINORITY CANCER SURVIVORS' PERCEPTIONS AND EXPERIENCE WITH CANCER CLINICAL TRIALS PARTICIPATION

Bayer, L. L.

16 * THE PRICE OF EMERGENCY CONTRACEPTION IN THE UNITED STATES: WHAT IS THE COST-EFFECTIVENESS OF ULIPRISTAL ACETATE VERSUS SINGLE DOSE LEVONORGESTREL?

Bayley, J. C.

N-5 ANATOMIC VS. FUNCTIONAL TESTING IN PATIENTS WITH STABLE CHRONIC CHEST PAIN SYNDROME AND THE EFFECT OF NON-OBSTRUCTIVE CORONARY ARTERY DISEASE – A COST-EFFECTIVENESS ANALYSIS

Bayoumi, A. M.

C-1 DEVELOPING A COMPLEX AGENT NETWORK MODEL TO PREDICT HIV AND HCV INCIDENCE IN CANADA

L HEALTH ECONOMICS LUSTED FINALISTS.

Baysari, M.

3 DIAGNOSTIC ERROR AT THE EMERGENCY DEPARTMENT — MEDICAL IMAGING INTERFACE: AN AUSTRALASIAN SURVEY

Beasley, IV, W. H.

10 DEMONSTRATION OF A BALANCE BEAM AID FOR INSTRUCTION IN DIAGNOSIS

57 ENTROPY-BASED EXPECTED UNCERTAINTY REDUCTION TO GUIDE THE CLINICAL EXAM

Beaton, D. E.

52 WITHDRAWN - AN ASSESSMENT OF THE MODIFIED RANKIN SCALE AS A STROKE OUTCOME MEASURE IN ECONOMIC ANALYSES OF ACUTE ISCHEMIC STROKE OUTCOMES

Beca, J.

17 IS CYP2D6 GENETIC TEST IN COMBINATION WITH HORMONE THERAPY FOR ER+ HORMONE SENSITIVE WOMEN WITH EARLY BREAST CANCER COST-EFFECTIVE?

Beck, J. .. R.

15 DOES IMPROVED NUMERACY MAKE THE GLASS HALF FULL? CANCER PATIENTS' OPTIMISM, NUMERACY, AND PERCEPTIONS OF THE COSTS OF TREATMENT

Beckstead, J. W.

AM11 PSYCHOLOGY OF MEDICAL DIAGNOSIS

Bego-Le Bagousse, G.

N-1 DRONEDARONE COST OFFSET ACHIEVED BY REDUCTION OF ATRIAL FIBRILLATION/FLUTTER PATIENT HOSPITALIZATION: RESULTS FROM THE FIRST 12 MONTHS OF FOLLOW-UP DURING THE ATHENA TRIAL

Bekker, H. L.

12 TRAINING HEALTH PROFESSIONALS IN SHARED DECISION MAKING: AN INTERNATIONAL ENVIRONMENTAL SCAN

Belanger, E.

19 REVISITING THE ONTOLOGY OF SHARED DECISION-MAKING IN PALLIATIVE CARE USING CRITICAL DISCURSIVE PSYCHOLOGY

M DECISION AIDS AND DECISION SUPPORT

Belkora, J. K.

41 THE QUALITY OF DECISIONS ABOUT BREAST CANCER SURGERY

Belozeroff, V.

37 ROBUSTNESS OF COST-EFFECTIVENESS ESTIMATES FOR CINACALCET IN SECONDARY HYPERPARATHYROIDISM BASED ON THE ADVANCE TRIAL

Bendavid, E.

13 * BALANCING CARDIAC RISK AND IMMUNOLOGIC BENEFITS IN DECISIONS ON HIV ANTIRETROVIRAL TREATMENT INITIATION

E-1 * THE COST-EFFECTIVENESS OF SYMPTOM-BASED TESTING AND ROUTINE SCREENING FOR ACUTE HIV INFECTION IN MEN WHO HAVE SEX WITH MEN IN THE UNITED STATES

E-5 * THE COST-EFFECTIVENESS OF PREEXPOSURE PROPHYLAXIS FOR HIV PREVENTION IN MEN WHO HAVE SEX WITH MEN IN THE UNITED STATES

Benjamin, L.

TR1-2 FACTORS INFLUENCING PHYSICIANS' THERAPEUTIC DECISION WHEN PRESCRIBING CHEMOTHERAPY: A DISCRETE CHOICE EXPERIMENT

Bennett, C.

D-1 TOWARD MINIMUM STANDARDS FOR THE CERTIFICATION OF PATIENT DECISION AIDS: A CORRELATION ANALYSIS AND MODIFIED DELPHI CONSENSUS PROCESS

Bentley, T. G.

B-5 A FRAMEWORK FOR MEASURING THE VALUE OF QUALITY IMPROVEMENT

Berg, B.

L-2 * ESTIMATING THE COST OF NO-SHOWS AND EVALUATING THE EFFECTS OF MITIGATION STRATEGIES

Berg, S.

9 CAN HEALTH COACHING HELP PATIENTS WITH SPINAL STENOSIS MAKE AN INFORMED TREATMENT CHOICE?

18 CAN A DECISION SUPPORT PROGRAM HELP A COHORT OF MS PATIENTS WITH DEPRESSION? IMPLEMENTATION OF A DECISION SUPPORT PROGRAM IN A MULTIPLE SCLEROSIS-PSYCHIATRIC CLINICAL MICROSYSTEM

Bernstein, D.

A CASE IN WHICH A BABY TAUGHT AN ATTENDING

Bessman, E. S.

26 * MAXIMIZERS AND SATISFICERS IN THE EMERGENCY DEPARTMENT

Best, T. J.

H-6 * USE OF DEDICATED WINGS TO MAXIMIZE INSTITUTIONAL OBJECTIVES UNDER STRAINED BED CAPACITY

Beusterien, K. M.

40 DEVELOPMENT AND VALIDATION OF A GLAUCOMA SPECIFIC UTILITY ELICITATION INSTRUMENT

Bhargava, M.

14 * BLACK RACE IS ASSOCIATED WITH PREFERENTIAL USE OF HOSPICE AT HOME VERSUS AT A SKILLED NURSING FACILITY

Bhattacharya, J.

14 * BLACK RACE IS ASSOCIATED WITH PREFERENTIAL USE OF HOSPICE AT HOME VERSUS AT A SKILLED NURSING FACILITY

Biessen, E. A.

8 * USE OF HIGH-SENSITIVE TROPONIN T ASSAY FOR THE EARLY DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION IN CHEST PAIN PATIENTS: AN ECONOMIC EVALUATION

Binns-Calvey, A.

15 COMPARING ANNOUNCED WITH UNANNOUNCED STANDARDIZED PATIENTS FOR ASSESSING DIAGNOSTIC ERROR

Biousse, V.

2 NON-MYDRIATIC FUNDUS PHOTOGRAPHY FOR IMPROVED DIAGNOSIS OF ACUTE NEURO-OPHTHALMIC DISEASE IN THE EMERGENCY DEPARTMENT (ED)

Birnbaum, J. K.

26 CANTRANCE: FROM CANCER COMPARATIVE EFFECTIVENESS STUDIES TO DISEASE-SPECIFIC MORTALITY

Bishop, I. J.

58 CULTURAL VARIABILITY AMONG HISPANICS ON KNOWLEDGE OF THE HUMAN PAPILLOMAVIRUS

Bitterauf, M.

D-4 IMPLEMENTING SHARED DECISION MAKING IN A MULTICULTURAL PRACTICE: A COLLABORATIVE PRIMARY CARE-HEALTH EDUCATOR APPROACH

Blackford, A.

25 ARE INDICATORS OF QUALITY CARE FOR COMORBID CONDITIONS ASSOCIATED WITH COSTS OF CARE FOR PROSTATE, BREAST, AND COLORECTAL CANCER SURVIVORS AND MATCHED CONTROLS?

Blackhouse, G.

19 COVERAGE WITH EVIDENCE DEVELOPMENT IN ONTARIO: EXPERIENCE WITH DESIGNING FIELD EVALUATIONS TO INFORM HEALTH POLICY DECISIONS

22 * CATHETER ABLATION STRATEGIES FOR RHYTHM CONTROL IN PATIENTS WITH ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS

44 COST-EFFECTIVENESS OF PULMONARY VEIN ABLATION FOR ATRIAL FIBRILLATION IN CANADA

Blake, K. B.

34 ASSESSING THE INFLUENCE OF DELAY DISCOUNTING OF FUTURE HEALTH ON DIET AND PHYSICAL ACTIVITY BEHAVIORS: DOES IT DIFFER BY BODY MASS INDEX CATEGORY?

Blalock, S. J.

43 * HOW DO PATIENTS RESOLVE CONFLICTING MEDICATION RELATED INFORMATION?

53 SOURCES OF CONFLICTING MEDICATION INFORMATION: ASSOCIATIONS WITH DEMOGRAPHIC FACTORS AND MEDICATION ADHERENCE

Blum, S. I.

35 BUDGETARY IMPACT OF ADDING ROFLUMILAST TO MANAGED CARE FORMULARY IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Blumenthal-Barby, J.

29 QUESTIONING THE NEUTRALITY OF DECISION AIDS

BD1-1 1:30 - 1:53 PM - INTEGRATING ETHICS INTO THE SCIENCE OF BEHAVIOR CHANGE

Boer, R.

37 ROBUSTNESS OF COST-EFFECTIVENESS ESTIMATES FOR CINACALCET IN SECONDARY HYPERPARATHYROIDISM BASED ON THE ADVANCE TRIAL

Bojke, L.

50 * EXPERT ELICITATION TO POPULATE EARLY HEALTH ECONOMIC MODELS OF MEDICAL DIAGNOSTIC DEVICES IN DEVELOPMENT

Bolge, S. C.

50 LONGITUDINAL ANALYSIS OF GOLIMUMAB UTILIZATION: EVIDENCE FROM THE WOLTERS KLUWER SOURCE®LX NATIONAL HEALTH CLAIMS DATABASE

52 PATIENT PERCEPTIONS AND EXPERIENCES WITH SITES OF CARE (SOCS) AMONG PATIENTS WITH IMMUNOLOGY CONDITIONS CURRENTLY USING INTRAVENOUS (IV) BIOLOGIC THERAPY

57 GOLIMUMAB BUDGET IMPACT MODEL

Bond, R.

38 MODELLING PATIENTS' PSYCHOLOGICAL CHARACTERISTICS, SELF-CARE BEHAVIOURS AND CLINICAL OUTCOMES TO INFORM A PATIENT-LEVEL SIMULATION MODEL OF DIABETES

Bongaerts, B. W.

8 * USE OF HIGH-SENSITIVE TROPONIN T ASSAY FOR THE EARLY DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION IN CHEST PAIN PATIENTS: AN ECONOMIC EVALUATION

Boohaker, E.

33 PATIENT PRIORITIES REGARDING CURRENTLY RECOMMENDED COLORECTAL CANCER SCREENING OPTIONS

Boonen, A.

49 CONSEQUENCES OF WITHDRAWING THE SECOND TUMOUR NECROSIS FACTOR α ANTAGONIST IN SEQUENTIAL TREATMENTS OF ACTIVE ANKYLOSING SPONDYLITIS: A HEALTH-ECONOMICAL PERSPECTIVE USING A POPULATION DYNAMICS SIMULATION MODEL

Borah, B. J.

B-2 A PRAGMATIC APPROACH FOR ASSESSING PREDICTORS OF MEDICATION ADHERENCE

Bordage, G.

REDUCING COGNITIVE ERRORS BY CAPTURING AND DISSEMINATING EXPERT REASONING

Bornschein, B.

TR2-1 COST-EFFECTIVENESS AND PUBLIC HEALTH/BUDGET-IMPACT OF FFR-GUIDED PCI IN MULTIVESSEL PATIENTS IN 6 EUROPEAN COUNTRIES - ANALYSIS ALONG THE FAME TRIAL DATA

Botler, J.

22 A RESTRUCTURED ROOT CAUSE ANALYSIS PROCESS FOR SUSPECTED DIAGNOSTIC ERROR

Bourmaud, A.

22 DECIDEO : INFORMED DECISION AND PARTICIPATION OF WOMEN TO THE NATIONAL SCREENING FOR BREAST CANCER : A QUALITATIVE OVERVIEW

Bowen, J.

53 DATA ANALYSIS WITH LARGE NUMBERS OF MISSING BODY MASS INDEX VALUES

Bowen, J. M.

19 COVERAGE WITH EVIDENCE DEVELOPMENT IN ONTARIO: EXPERIENCE WITH DESIGNING FIELD EVALUATIONS TO INFORM HEALTH POLICY DECISIONS

39 CHARACTERIZING THE UTILIZATION OF MAGNETOENCEPHALOGRAPHY IN THE DETERMINATION OF SURGICAL CANDIDACY IN CHILDREN AND ADOLESCENTS WITH MEDICALLY REFRACTORY EPILEPSY – A FIELD EVALUATION TO INFORM HEALTH POLICY

Bradley, L.

55 COMPARATIVE EFFECTIVENESS OF ANTIARRHYTHMIC DRUG THERAPY IN ATRIAL FIBRILLATION: FOCUS ON CARDIOVASCULAR HOSPITALIZATION AND MORTALITY OUTCOMES

Brady, T. J.

N-5 ANATOMIC VS. FUNCTIONAL TESTING IN PATIENTS WITH STABLE CHRONIC CHEST PAIN SYNDROME AND THE EFFECT OF NON-OBSTRUCTIVE CORONARY ARTERY DISEASE – A COST-EFFECTIVENESS ANALYSIS

Brailsford, S.

AM8 MODELING APPROACHES FOR ANALYSING HEALTH CARE PROBLEMS – AN INTRODUCTORY OVERVIEW AND COMPARISON

Braithwaite, R. S.

15 DIAGNOSTIC VALUE OF IMAGING IN SYSTEMIC EMBOLISM

B HEALTH TECHNOLOGY AND OUTCOMES RESEARCH

I-3 * APPLYING THE PAYOFF TIME FRAMEWORK TO CAROTID DISEASE MANAGEMENT

Brandeau, M. L.

13 * BALANCING CARDIAC RISK AND IMMUNOLOGIC BENEFITS IN DECISIONS ON HIV ANTIRETROVIRAL TREATMENT INITIATION

C MODELING AND SIMULATION METHODS

E-1 * THE COST-EFFECTIVENESS OF SYMPTOM-BASED TESTING AND ROUTINE SCREENING FOR ACUTE HIV INFECTION IN MEN WHO HAVE SEX WITH MEN IN THE UNITED STATES

E-5 * THE COST-EFFECTIVENESS OF PREEXPOSURE PROPHYLAXIS FOR HIV PREVENTION IN MEN WHO HAVE SEX WITH MEN IN THE UNITED STATES

Bravata, D. M.

5 USAGE AND CHARACTERISTICS OF PATIENT SATISFACTION WEBSITES

29 REFERENCE PRICING: AN INNOVATIVE BENEFIT DESIGN FOR CONTROLLING MEDICAL EXPENDITURES

41 PRICE TRANSPARENCY: AN INNOVATIVE MEANS OF CONTROLLING MEDICAL EXPENDITURES?

Brehaut, J. C.

M-5 DO INFORMED CONSENT DOCUMENTS MAKE GOOD DECISION AIDS?

Breitenecker, F.

16 * ANALYZING CLAIMS DATA FOR HEALTH SERVICES USE IN CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER

48 EVALUATION OF CANCER INCIDENCE IN AUSTRIA AND TREATMENT PATHWAY IDENTIFICATION IN INTRAMURAL AND EXTRAMURAL HEALTH CARE BASED ON LONGITUDINAL ACCOUNTING DATA

E-6 * SOCIAL INTERACTION MODULES IN EPIDEMIC MODELS FOR THE SIMULATION OF INFECTIOUS DISEASES AND EVALUATION OF INTERVENTIONS

Bremner, K. E.

G-3 PREDICTING UTILITY SCORES FOR PROSTATE CANCER: MAPPING THE PROSTATE CANCER INDEX TO THE PATIENT ORIENTED PROSTATE UTILITY SCALE (PORPUS)

O-5 USING LARGE ADMINISTRATIVE DATASETS AND CHART REVIEWS TO ESTIMATE COSTS FOR HEALTH STATES: THE CASE OF PROSTATE CANCER

Brennan, A.

38 MODELLING PATIENTS' PSYCHOLOGICAL CHARACTERISTICS, SELF-CARE BEHAVIOURS AND CLINICAL OUTCOMES TO INFORM A PATIENT-LEVEL SIMULATION MODEL OF DIABETES

55 DEVELOPING AN INTEGRATED RESEARCH PROGRAMME TO EXPLORE PATIENT BEHAVIOUR, CLINICAL OUTCOMES AND HEALTH ECONOMICS IN TYPE 1 DIABETES

Brewer, N. T.

42 * DOES MESSAGE SOURCE AFFECT PARENTS' RESPONSES TO ADS PROMOTING HPV VACCINE FOR BOYS?

Bridges, J. F.

28 RANDOMIZED TRIAL OF PAIRED AND TRIPLET PROFILE CHOICE TASKS IN THE ELICITATION OF PATIENT PREFERENCES FOR HEARING AIDS WITH CONJOINT ANALYSIS

30 MEASURING STATED PREFERENCES TO IDENTITY ATTRIBUTE IMPORTANCE: IS IT A CASE OF 1 ATTRIBUTE WITH N LEVELS OR N ATTRIBUTES WITH ONLY 1 LEVEL

FD1 APPLYING CONJOINT ANALYSIS AND DISCRETE CHOICE EXPERIMENTS IN HEALTH

Britto, M. T.

10 “THE HARDEST DECISION I EVER HAD”: PARENT DECISION MAKING ABOUT TNF-α INHIBITOR TREATMENT

Broder, M. S.

B-5 A FRAMEWORK FOR MEASURING THE VALUE OF QUALITY IMPROVEMENT

Brooker, A.

7 INTEGRATING QUANTITATIVE PREFERENCE-RELATED EVIDENCE INTO HEALTH TECHNOLOGY ASSESSMENT: THE CASE OF VENTILATION FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Brown, D.

12 EMERGENCY DEPARTMENT DIZZINESS PRESENTATIONS WITH SUBSEQUENT STROKE: CASE DESCRIPTIONS FROM A POPULATION-BASED STUDY

Brown, L.

39 CHARACTERIZING THE UTILIZATION OF MAGNETOENCEPHALOGRAPHY IN THE DETERMINATION OF SURGICAL CANDIDACY IN CHILDREN AND ADOLESCENTS WITH MEDICALLY REFRACTORY EPILEPSY – A FIELD EVALUATION TO INFORM HEALTH POLICY

Bruce, B. B.

2 NON-MYDRIATIC FUNDUS PHOTOGRAPHY FOR IMPROVED DIAGNOSIS OF ACUTE NEURO-OPHTHALMIC DISEASE IN THE EMERGENCY DEPARTMENT (ED)

Bruny, J.

D-2 WHO IS GUIDING DECISIONS ABOUT WHETHER TO PERFORM PEDIATRIC GASTRIC FUNDOPLICATION?

Brust, P. G.

A-6 * REWARD SENSITIVITY, TEMPORAL DISCOUNTING, GENDER AND RISKY HEALTH BEHAVIORS: A FUZZY-TRACE THEORY APPROACH

Bryan, S.

30 VALUE CLARIFICATION IN DECISION AIDS: A MISSING ELEMENT?

Bryce, C. L.

F-4 A RANDOMIZED TRIAL OF DEFAULT OPTIONS IN ADVANCE DIRECTIVES FOR PATIENTS WITH TERMINAL LUNG DISEASES

Bryg, D. J.

B-6 HISTORICAL CONTROLS FOR MORTALITY: R.I.P

Bryg, R. J.

B-6 HISTORICAL CONTROLS FOR MORTALITY: R.I.P

Bullard, K. M.

N-4 OPTIMAL CUT-POINT OF DIABETES RISK SCORES TO IDENTIFY UNDIAGNOSED DIABETES: A COST-EFFECTIVENESS PERSPECTIVE

Burger, E.

H-1 * COST-EFFECTIVENESS OF PRIMARY HUMAN PAPILLOMAVIRUS (HPV) TESTING IN NORWAY

Burke, J.

12 EMERGENCY DEPARTMENT DIZZINESS PRESENTATIONS WITH SUBSEQUENT STROKE: CASE DESCRIPTIONS FROM A POPULATION-BASED STUDY

Burke, N.

19 COVERAGE WITH EVIDENCE DEVELOPMENT IN ONTARIO: EXPERIENCE WITH DESIGNING FIELD EVALUATIONS TO INFORM HEALTH POLICY DECISIONS

39 CHARACTERIZING THE UTILIZATION OF MAGNETOENCEPHALOGRAPHY IN THE DETERMINATION OF SURGICAL CANDIDACY IN CHILDREN AND ADOLESCENTS WITH MEDICALLY REFRACTORY EPILEPSY – A FIELD EVALUATION TO INFORM HEALTH POLICY

Burnside, E. S.

56 DETERMINING THE MOST INFORMATIVE MAMMOGRAPHIC FEATURES IN BREAST CANCER DIAGNOSIS BY MULTIDIMENSIONAL MUTUAL INFORMATION ANALYSIS AND BAYESIAN REASONING

AM7 MEDICAL DECISION MAKING WITH BAYESIAN NETWORKS

I-6 EXPECTED UTILITY MODEL USED TO COMPARE THE VALUE OF SCREENING VERSUS DIAGNOSTIC MAMMOGRAPHY

Burton, K. R.

52 WITHDRAWN - AN ASSESSMENT OF THE MODIFIED RANKIN SCALE AS A STROKE OUTCOME MEASURE IN ECONOMIC ANALYSES OF ACUTE ISCHEMIC STROKE OUTCOMES

Buttorff, C.

28 RANDOMIZED TRIAL OF PAIRED AND TRIPLET PROFILE CHOICE TASKS IN THE ELICITATION OF PATIENT PREFERENCES FOR HEARING AIDS WITH CONJOINT ANALYSIS

Bynum, J.

45 ASSESSING THE QUALITY OF BREAST CANCER SURGERY DECISIONS IN A NATIONAL MEDICARE SAMPLE